Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial sorbitol-6-phosphate dehydrogenase and sorbitol-specific transporters constitute a specialized metabolic pathway used by various bacteria, including the dental pathogen Streptococcus mutans and enteric bacteria like Escherichia coli, to utilize sorbitol as a carbon source (UniProt P0A9S1). The transport system, usually a component of the phosphoenolpyruvate-dependent phosphotransferase system (PTS), facilitates the import of sorbitol while simultaneously phosphorylating it to sorbitol-6-phosphate (PubMed 25651384). Subsequently, sorbitol-6-phosphate dehydrogenase (EC 1.1.1.140) catalyzes the NAD+-dependent oxidation of this intermediate into fructose-6-phosphate, which enters the glycolytic pathway to produce energy and organic acids (KEGG entry C00191). This system is a primary target for anti-caries agents like xylitol, which acts as a decoy substrate; it is transported and phosphorylated by the PTS but cannot be further metabolized by the dehydrogenase, resulting in the toxic accumulation of xylitol-5-phosphate and the inhibition of bacterial growth (PubMed 1695368). Targeting these proteins offers a strategy to modulate the oral and gut microbiome by selectively inhibiting bacteria that rely on these pathways for competitive survival.
Competitive inhibition of sorbitol uptake and induction of a futile metabolic cycle through the accumulation of non-metabolizable sugar phosphates, leading to ATP depletion and growth inhibition.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial sorbitol-6-phosphate dehydrogenase and sorbitol-specific phosphotransferase system (S6PDH/Sor-PTS).